Prescription-related illness - A scandalous pandemic

Journal of Evaluation in Clinical Practice

Volumn 10, Issue 4, 2004, Pages 491-497

  McGavock, Hugh ^a,b  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Causes; Prescription related illness: Extent; Recommendations

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTITUSSIVE AGENT; ANTIULCER AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DERMATOLOGICAL AGENT; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PERIPHERAL VASODILATING AGENT; PROTON PUMP INHIBITOR; STEROID;

DIAGNOSTIC ERROR; DRUG INDUCED DISEASE; DRUG INDUSTRY; DRUG MARKETING; DRUG POTENCY; DRUG RESEARCH; DRUG USE; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HUMAN; KIDNEY DYSFUNCTION; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICATION ERROR; MORBIDITY; MORTALITY; POLYPHARMACY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW;

AGED; DIAGNOSTIC ERRORS; DRUG INDUSTRY; DRUG THERAPY; EVIDENCE-BASED MEDICINE; GERIATRICS; GREAT BRITAIN; HUMANS; MEDICATION ERRORS; POLYPHARMACY; PRESCRIPTIONS, DRUG;

EID: 7944235586     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2003.00471.x     Document Type: Review

References (12)

1. Connolly J.P. & McGavock H. (1999) Antibiotic prescribing for respiratory tract infections in general practice. Pharmacoepidemiology & Drug Safety 8, 95-104.
2. Connolly J.P., McGavock H. & Wilson-Davis K. (1998) Peripheral vasodilators and the management of peripheral vascular disease and Raynaud's syndrome in general practice. Pharmacoepidemiology & Drug Safety 7, 189-196.
3. Ebbeson J., Buajordet I., Erikssen J. et al. (2001) Drug-related deaths in a department of internal medicine. Archives of Internal Medicine 161, 2317-2323.
4. Huang B., Bachmann K.A., Xuming H. et al. (2002) Inappropriate prescriptions for the aging population of the United States: an analysis of the National Ambulatory Medical Care Survey, 1997. Pharmacoepidemiology & Drug Safety 11, 127-134.
5. May F. & Rowett D. (2000) DATIS - academic drug detailing to general practitioners - techniques problems and outcomes. In Handbook of Drug Use Research Methodology, 1st edn. UK Drug Utilization Research Group. Available from Professor S. Chapman, Department of Medicines Management, University of Keele, Staffordshire, England ST5 5BL.
6. McGavock H. & Wilson-Davis K. (2000) The Belfast Classification - aggregating drugs according to the specificity of their use in general practice. In Handbook of Drug Use Research Methodology, 1st edn, pp. 164-175. UK Drug Utilization Research Group. Available from Professor S. Chapman, Department of Medicines Management, University of Keele, Staffordshire, England ST5 5BL.
7. McGavock H., Wilson-Davis K., Rafferty T. et al. (1998) The Prescribing Jigsaw - Studies in General Practitioner Prescribing, 1990-98. Drug Utilisation Research Unit, Queen's University, Belfast, p. 259.
8. NHS (2003) Clinical Evidence - An NHS internet Source for Physicians. http://www.clinicalevidence.com
9. Pirohamed M., Breckenridge A.M., Kitteringham N.R. et al. (1998) Adverse drug reactions. British Medical Journal 316, 1295-1298.
10. Strom B.L., Carson J.L., Morse M.L. et al. (1985) COMPASS, the computerized on-line medicaid pharmaceutical analysis and surveillance system: a new resource for post-marketing drug surveillance. Clinical Pharmacology and Therapeutics 38, 359-364.
11. Von Ferber L., Koster I., Schubert I. et al. (2000) How to set up and run prescribing quality study groups for general practitioners, including problems and outcomes. In Handbook of Drug Use Research Methodology, 1st edn, pp. 7-215. UK Drug Utilization Research Group. Available from Professor S. Chapman, Department of Medicines Management, University of Keele, Staffordshire, England ST5 5BL.
12. Williamson J. & Chaplin J.M. (1980) Adverse drug reactions to prescribed drugs in the elderly: a multi-centre investigation. Age and Ageing 9, 73-80.